UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
Read more on Pittsburgh Business Times.
Pittsburgh Business Times: UPMC Enterprises invests in prescription analytics company RxAnte
Related Resources
More Resources
08.13.18
MAPD Plans and the LIS Population
Blog Post
With the uniqueness of the LIS population comes an equally unique opportunity for MAPD plans: even small changes can make big differences. Specifically, plans can improve member care and outcomes among seniors by addressing key challenges affecting LIS members.
08.09.18
Empowering Health Plans to Control the Future of Medication Adherence
Case Study
08.06.18
What Telehealth Really Means for Health Plans
Blog Post
With 44 digital health mergers and acquisitions in 2017 and new health ventures in 2018 that include companies like Amazon and Wal-Mart, the age of health tech innovation is just getting started.